Skip to content
Screener

West Pharmaceutical Services WST Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
$31.88M+10.0%
Dow logo
DowDOW
$341M+4.9%
Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
$503.02K+30.3%
Sonoco Products logo
Sonoco ProductsSON
$53.17M-6.5%
Trimas logo
TrimasTRS
$6.62M-23.4%
UFP Technologies logo
UFP TechnologiesUFPT
$4.73M+1.3%

Other financials

Income statement

See full
Revenue$872.3M+13.8%
Gross profit$329.2M+20.2%
Operating income$179.1M+16.5%
Net income$154.0M+16.8%
EPS (diluted)$2.15+18.1%

Balance sheet

See full
Cash & equivalents$435.8M-14.5%
Total debt$316.5M+2.7%
Total equity$3.0B+2.1%
Total assets$4.1B+3.1%

Cash flow

See full
Operating cash flow$124.0M-30.0%
CapEx$43.2M-42.6%
Free cash flow$80.8M-20.7%

Valuation

See full
Market cap$24.92B+44.2%
Enterprise value$24.8B+45.2%
P/E44.1×+8.7×
P/S7.5×+1.7×

Profitability

See full
Gross margin36.8%+1.5pp
Operating margin20.5%+0.8pp
Net margin17%+0.5pp
FCF margin13.1%+1.5pp

Returns & leverage

See full
Return on equity19.1%+1.4pp
Debt / equity0.1×0.0×
Current ratio2.8×0.0×

Where this comes from

Reported directly by West Pharmaceutical Services in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.

The source filing: West Pharmaceutical Services’s 10-Q, filed July 23, 2026.

Filed
Jul 23, 2026, 4:15 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000105770-26-000099
(in millions, except per share data)June 30,2026December 31,2025
Accounts payable$252.7$253.7
Accrued salaries, wages and benefits97.1135.9
Income taxes payable64.728.1
Operating lease liabilities20.922.7
Accrued commissions, rebates and royalties34.039.2
Other current liabilities171.1175.3
Total current liabilities640.5654.9
Long-term debt202.9202.8

Item 1. FINANCIAL STATEMENTS (UNAUDITED)

FAQ

What is West Pharmaceutical Services's operating lease liabilities (current)?
West Pharmaceutical Services (WST) reported operating lease liabilities (current) of $20.9M in Q2 2026.
How has West Pharmaceutical Services's operating lease liabilities (current) changed year-over-year?
West Pharmaceutical Services's operating lease liabilities (current) decreased by 0.0% year-over-year, from $20.9M to $20.9M.
What is the long-term trend for West Pharmaceutical Services's operating lease liabilities (current)?
Over 5 years (2020 to 2025), West Pharmaceutical Services's operating lease liabilities (current) has grown at a 17.6% compound annual growth rate (CAGR), from $10.1M to $22.7M.
What does operating lease liabilities (current) mean?
The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.

Ask your AI about West Pharmaceutical Services's operating lease liabilities (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude